在囊性纤维化和非囊性纤维化支气管切除症中的微生物组比较分析
Heryk Motta1, Júlia Catarina Vieira Reuwsaat1, Fernanda Cortez Lopes2,3
1Laboratório de Biologia Molecular de Patógenos, Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Respiratory research
|May 18, 2024
概括
与健康个体相比,支气管切除症患者的呼吸道微生物多样性减少,抗微生物耐药性基因发生变化. 囊性纤维化和非CF支气管炎具有不同的微生物组配置,需要量身定制的治疗方法.
科学领域:
- 微生物学 微生物学
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 支气管炎症,包括囊性纤维化 (CF) 和非CF支气管炎 (NCFB),涉及不可逆转的支气管扩张和肺损伤.
- 复发性感染和炎症导致支气管炎症的疾病进展.
- 了解呼吸道微生物群对于识别变化和抗菌素敏感性至关重要.
研究的目的:
- 描述和比较CF,NCFB和健康个体的呼吸道微生物组和抗菌素耐药性基因配置文件.
- 为了确定CF和NCFB患者之间的关键微生物差异.
主要方法:
- 招募了35名受试者:10名NCFB,13名CF患者和12名健康对照.
- 采集了鼻口腔抽样和诱导的唾液用于DNA提取.
- 利用猎枪测序和SqueezeMeta管道进行微生物群和抗体分析.
主要成果:
- 与健康对照人群相比,CF和NCFB队列中观察到微生物多样性的减少.
- 在疾病组之间确定了不同的微生物组成和抗微生物耐药性基因配置文件.
- CF队列显示了Burkholderiaceae的丰富性和更高的Firmicutes/Bacteroidetes比率;金黄色葡萄球菌和Prevotella shahii在CF和NCFB中分别有差异性丰度.
结论:
- 支气管切除与微生物多样性减少以及微生物组和抗体组合的改变有关.
- 在CF和NCFB之间存在微生物组和抗菌素耐药性的显著差异.
- 这些发现凸显了CF和NCFB个性化管理策略的需要.
更多相关视频
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
2.4K
11:23Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
Published on: December 22, 2014
37.3K
相关概念视频
Cystic Fibrosis: Pathogenesis
218
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
218
Cystic Fibrosis: Management
155
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
155
